Homeopathic Treatment of Post-acute COVID-19 Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Post-acute Covid-19 Syndrome
Interventions
DRUG

Homeopathic Medication

Homeopathic medicines are prepared according to standardized methods as specified by the Homeopathic Pharmacopoeia of the United States (HPUS), which was mandated by Congress to regulate the manufacture of homeopathic medicines as part of the Food, Drug, and Cosmetics Act of 1939. All homeopathic medicines prescribed in this study must be found in the HPUS. For a complete list of homeopathic medicines, contact the researchers.

OTHER

Placebo

Inert lactose pellets

Trial Locations (1)

85282

Southwest College of Naturopathic Medicine, Tempe

All Listed Sponsors
collaborator

Samueli Institute for Information Biology

OTHER

lead

Southwest College of Naturopathic Medicine

OTHER

NCT05104749 - Homeopathic Treatment of Post-acute COVID-19 Syndrome | Biotech Hunter | Biotech Hunter